ClinicalTrials.gov record
MRI Sarcoma Non Invasive Thermometry
COMPLETED · NCT00093509
Trial record
NCT IDNCT00093509
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE1, PHASE2
Enrollment
15
Conditions
Sarcoma
Interventions
doxorubicin hydrochloride, ifosfamide and mesna, hyperthermia treatment with an MRI Compatible Radiofrequency Extremity Hyperthermia Applicator, radiation therapy
Locations
Duke Cancer Institute, Durham, North Carolina, United States
Indexed topics
Last update
2014-08-29